A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors

NANot yet recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

April 1, 2024

Primary Completion Date

February 1, 2026

Study Completion Date

May 1, 2028

Conditions
Desmoid TumorDesmoid FibromatosisDesmoid
Interventions
PROCEDURE

radiofrequency ablation

"Anesthesia: Local (Novocaine, Lidocaine, Bupivacaine) Access: transcutaneous Navigation under CT control Cannulas are used: 22G 100 and 150 mm, the size of the electrode corresponds to the size of the cannula The starting power is 20W followed by steps of 10W every 2 minutes until the maximum power is reached, the maximum power is 60W.~In order to prevent infectious complications, two-day antibiotic prophylaxis of Cefazolin (1g) is carried out 3 times a day In order to prevent skin burns with superficially located DFS, the skin is cooled during the procedure."

Trial Locations (1)

115522

"Federal State Budgetary Institution N.N. Blokhin National Medical Research Center of Oncology оf the Ministry of Health of the Russian Federation (N.N. Blokhin NMRCO)", Moscow

All Listed Sponsors
lead

Blokhin's Russian Cancer Research Center

OTHER

NCT06355921 - A Prospective Clinical Study on the Safety and Efficacy of Radiofrequency Ablation for the Treatment of Patients With Desmoid Tumors | Biotech Hunter | Biotech Hunter